ROBYN MCCARTY: Open Payments
NPI 1932860129 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,306 in 62 payments from 18 companies in 2025. Trend: 2023 $851 · 2024 $900 · 2025 $1,306
Food & beverage: $1,302Education: $4
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $386 |
| Amgen Inc. | 10 | $298 |
| Corcept Therapeutics | 13 | $209 |
| Insulet Corporation | 3 | $57 |
| Medtronic, Inc. | 2 | $46 |
| Madrigal Pharmaceuticals | 2 | $46 |
| SHIELD THERAPEUTICS INC | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 1 | $35 |
| Echosens North America, Inc. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
Products named: Korlym, Wegovy, TAVNEOS, Ozempic, TEPEZZA, Rybelsus, Omnipod, MINIMED 780G.
Industry payments across KY — which companies pay providers there.
